207 related articles for article (PubMed ID: 9187933)
1. Apolipoprotein E genotyping and cerebrospinal fluid tau protein: implications for the clinical diagnosis of Alzheimer's disease.
Arai H; Higuchi S; Sasaki H
Gerontology; 1997; 43 Suppl 1():2-10. PubMed ID: 9187933
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E epsilon 4 allele in association with global cognitive performance and CSF markers in Alzheimer's disease.
Lasser RA; Dukoff R; Levy J; Levin R; Lehtimäki T; Seubert P; Sunderland T
Int J Geriatr Psychiatry; 1998 Nov; 13(11):767-74. PubMed ID: 9850873
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
4. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
6. Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele epsilon 4 during 14 months follow-up.
Blomberg M; Jensen M; Basun H; Lannfelt L; Wahlund LO
Neurosci Lett; 1996 Aug; 214(2-3):163-6. PubMed ID: 8878109
[TBL] [Abstract][Full Text] [Related]
7. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects.
Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP
J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259
[TBL] [Abstract][Full Text] [Related]
8. Effect of genetic risk factors and disease progression on the cerebrospinal fluid tau levels in Alzheimer's disease.
Arai H; Terajima M; Miura M; Higuchi S; Muramatsu T; Matsushita S; Machida N; Nakagawa T; Lee VM; Trojanowski JQ; Sasaki H
J Am Geriatr Soc; 1997 Oct; 45(10):1228-31. PubMed ID: 9329486
[TBL] [Abstract][Full Text] [Related]
9. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
Harrington CR; Louwagie J; Rossau R; Vanmechelen E; Perry RH; Perry EK; Xuereb JH; Roth M; Wischik CM
Am J Pathol; 1994 Dec; 145(6):1472-84. PubMed ID: 7992850
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study.
Andreasen N; Vanmechelen E; Van de Voorde A; Davidsson P; Hesse C; Tarvonen S; Räihä I; Sourander L; Winblad B; Blennow K
J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):298-305. PubMed ID: 9527138
[TBL] [Abstract][Full Text] [Related]
11. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
12. CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity.
Ganzer S; Arlt S; Schoder V; Buhmann C; Mandelkow EM; Finckh U; Beisiegel U; Naber D; Müller-Thomsen T
J Neural Transm (Vienna); 2003 Oct; 110(10):1149-60. PubMed ID: 14523627
[TBL] [Abstract][Full Text] [Related]
13. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
[TBL] [Abstract][Full Text] [Related]
14. CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease.
Tapiola T; Lehtovirta M; Ramberg J; Helisalmi S; Linnaranta K; Riekkinen P; Soininen H
Neurology; 1998 Jan; 50(1):169-74. PubMed ID: 9443475
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent decline in the apolipoprotein E level in cerebrospinal fluid from control subjects and its increase in cerebrospinal fluid from patients with Alzheimer's disease.
Fukuyama R; Mizuno T; Mori S; Yanagisawa K; Nakajima K; Fushiki S
Eur Neurol; 2000; 43(3):161-9. PubMed ID: 10765057
[TBL] [Abstract][Full Text] [Related]
16. [Cerebrospinal fluid protein tau levels in the differential diagnosis of Alzheimer's disease].
Schonknecht P; Pantel J; Werle E; Hartmann T; Essig M; Baudendistel K; Beyreuther K; Schroder J
Fortschr Neurol Psychiatr; 2000 Oct; 68(10):439-46. PubMed ID: 11103680
[TBL] [Abstract][Full Text] [Related]
17. Association of apolipoprotein epsilon 4 allele and neuropathologic findings in patients with dementia.
Martinoli MG; Trojanowski JQ; Schmidt ML; Arnold SE; Fujiwara TM; Lee VM; Hurtig H; Julien JP; Clark C
Acta Neuropathol; 1995; 90(3):239-43. PubMed ID: 8525796
[TBL] [Abstract][Full Text] [Related]
18. Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease.
Arai H; Terajima M; Miura M; Higuchi S; Muramatsu T; Machida N; Seiki H; Takase S; Clark CM; Lee VM
Ann Neurol; 1995 Oct; 38(4):649-52. PubMed ID: 7574462
[TBL] [Abstract][Full Text] [Related]
19. A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele.
Skoog I; Vanmechelen E; Andreasson LA; Palmertz B; Davidsson P; Hesse C; Blennow K
Neurodegeneration; 1995 Dec; 4(4):433-42. PubMed ID: 8846237
[TBL] [Abstract][Full Text] [Related]
20. Dependence of cerebrospinal fluid Tau protein levels on apolipoprotein E4 allele frequency in patients with Alzheimer's disease.
Golombowski S; Müller-Spahn F; Romig H; Mendla K; Hock C
Neurosci Lett; 1997 Apr; 225(3):213-5. PubMed ID: 9147408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
